Assessment of Serum Dopamine and Catechol-O-methyltransferase (COMT) Levels in Patients with Sleep Parafunction
摘要
Sleep bruxism (SB) is a repetitive jaw-muscle activity during sleep, with multifactorial etiology including neurochemical, psychological, and physiological factors. Dopamine and COMT play roles in motor control, pain perception, and stress regulation.
ObjectiveTo compare serum dopamine and COMT levels in patients with SB and healthy controls, while evaluating psychological stress, anxiety, sleep quality, and obstructive sleep apnea (OSA) risk.
MethodsThis cross-sectional study included 130 participants (65 SB patients, 65 controls). SB was diagnosed clinically based on a history of sleep bruxism for ≥ 6 months and signs such as tooth wear, scalloped tongue, prominent cheek lines, masticatory muscle fatigue, and morning joint noises. Psychological and sleep evaluations were conducted using HAM-A, PSS-4, PSQI, and STOP-Bang questionnaires. Blood samples were collected fasting in the morning; serum dopamine and COMT levels were measured via ELISA. Statistical analyses included t-tests, Chi-square, Pearson, and point-biserial correlations.
ResultsA total of 111 samples were analyzed. Mean dopamine (38.8 ± 4.3 vs. 43.9 ± 4.8 ng/mL, P = 0.427) and COMT levels (13.9 ± 1.2 vs. 13.0 ± 1.1 ng/mL, P = 0.607) showed no significant differences between SB patients and controls. SB patients exhibited higher anxiety and stress scores, poorer sleep quality, and a greater risk of OSA (34% vs. 12.1%, P = 0.006). A significant negative correlation was found between COMT levels and STOP-Bang scores (r = −0.23, P = 0.015).
ConclusionsPeripheral dopamine and COMT levels may not reliably indicate SB, suggesting central neurochemical mechanisms are more relevant. Psychological factors and sleep quality are significantly associated with SB. Future studies should employ standardized diagnostic tools (e.g., STAB) and objective recordings (e.g., polysomnography) to clarify neurochemical contributions.